Supremes to Hear Arguments on 'Fraud-on-the-Market' Claims
By Marie Powers
Monday, November 5, 2012
The Supreme Court is expected to hear oral arguments in Amgen Inc. v. Connecticut Retirement Plans and Trust Funds, in which the big biotech is appealing a decision from the Court of Appeals for the Ninth Circuit that upheld a federal district court's refusal to hear evidence rebutting fraud-on-the-market claims involving erythropoietins before it certified a class in the shareholder lawsuit.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.